Literature DB >> 3500426

Haemodynamics and oxygen metabolism in patients after reversible ischaemic attack or minor ischaemic stroke assessed with positron emission tomography.

M Itoh1, J Hatazawa, C Pozzilli, H Fukuda, Y Abe, T Fujiwara, K Kubota, K Yamaguchi, T Sato, H Watanabe.   

Abstract

Regional cerebral blood flow (CBF), blood volume (CBV) and oxygen metabolic rate (CMRO2) were evaluated and compared among normals, patients with recent reversible ischaemic attacks (RIAs) and patients with chronic minor infarction using positron emission tomography. Average CBF together with CMRO2 significantly decreased in the infarction group in the middle cerebral artery territory of the affected hemisphere while the mean values for RIAs were intermediate between the other two groups. CBV also reduced, however it was more preserved compared to flow as seen in decreased CBF/CBV values. Significant interhemispheric difference was found in CBF/CBV ratio, but it did not clearly correlate with OEF changes. Higher OEF was noted only in the restricted brain regions of RIAs where CBF showed large hemispheric asymmetry. However, in other regions, the coupled decline of blood flow and metabolism was found which suggests tissue damage or neuronal cell loss in the brain with previous RIA symptoms.

Entities:  

Mesh:

Year:  1987        PMID: 3500426     DOI: 10.1007/BF00341736

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  20 in total

Review 1.  Positron emission tomography and its application to the study of cerebrovascular disease in man.

Authors:  W J Powers; M E Raichle
Journal:  Stroke       Date:  1985 May-Jun       Impact factor: 7.914

2.  Positron emission tomography to assess cerebral perfusion.

Authors:  W J Powers; M E Raichle; R L Grubb
Journal:  Lancet       Date:  1985-01-12       Impact factor: 79.321

3.  Italian multicenter study on reversible cerebral ischemic attacks: population characteristics and methodology.

Authors:  C Fieschi; F Mariani; G L Brambilla; M Prencipe; F Tomasello; C Argentino; G Bono; L Candelise; L De Zanche; D Inzitari
Journal:  Stroke       Date:  1983 May-Jun       Impact factor: 7.914

4.  Incomplete cerebral infarction--focal incomplete ischemic tissue necrosis not leading to emollision.

Authors:  N A Lassen
Journal:  Stroke       Date:  1982 Jul-Aug       Impact factor: 7.914

5.  Progressive cerebral ischemia antedates cerebrovascular symptoms by two years.

Authors:  J S Meyer; R L Rogers; K F Mortel
Journal:  Ann Neurol       Date:  1984-09       Impact factor: 10.422

Review 6.  Lacunes.

Authors:  J P Mohr
Journal:  Stroke       Date:  1982 Jan-Feb       Impact factor: 7.914

7.  Measurement of regional cerebral blood volume by emission tomography.

Authors:  R L Grubb; M E Raichle; C S Higgins; J O Eichling
Journal:  Ann Neurol       Date:  1978-10       Impact factor: 10.422

8.  Outcome of 314 patients with transient ischemic attacks.

Authors:  A Muuronen; M Kaste
Journal:  Stroke       Date:  1982 Jan-Feb       Impact factor: 7.914

9.  Effects of stroke on local cerebral metabolism and perfusion: mapping by emission computed tomography of 18FDG and 13NH3.

Authors:  D E Kuhl; M E Phelps; A P Kowell; E J Metter; C Selin; J Winter
Journal:  Ann Neurol       Date:  1980-07       Impact factor: 10.422

10.  Transient ischemic attacks: a prospective study of 225 patients.

Authors:  J F Toole; C P Yuson; R Janeway; F Johnston; C Davis; A R Cordell; G Howard
Journal:  Neurology       Date:  1978-08       Impact factor: 9.910

View more
  2 in total

1.  Regional cerebral blood flow and metabolism in patients with transient global amnesia: a positron emission tomography study.

Authors:  K Fujii; S Sadoshima; T Ishitsuka; K Kusuda; Y Kuwabara; Y Ichiya; M Fujishima
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-05       Impact factor: 10.154

Review 2.  Assessment of pathophysiology of stroke by positron emission tomography.

Authors:  W D Heiss; K Herholz
Journal:  Eur J Nucl Med       Date:  1994-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.